Type of diabetes-Type 2 - Page 2 of 17 Posts on Medivizor
Navigation Menu

Type of diabetes-Type 2 Posts on Medivizor

Can combined therapy with sodium-glucose co-transporter 2 inhibitors and sulfonylureas affect the risk of hypoglycemia in patients with type 2 diabetes?

Can combined therapy with sodium-glucose co-transporter 2 inhibitors and sulfonylureas affect the risk of hypoglycemia in patients with type 2 diabetes?

Posted by on Dec 31, 2021 in Diabetes mellitus | 0 comments

In a nutshell This review assessed the risk of hypoglycemia (dangerously low blood glucose) with the addition of sodium-glucose co-transporter 2 (SGLT-2) inhibitors to sulfonylureas in patients with type 2 diabetes (T2D). The authors concluded that this combination was associated with an increased risk of hypoglycemia. Some background...

Read More

Improved changes in the eye in patients with type 2 diabetes using dapagliflozin compared to glibenclamide.

Improved changes in the eye in patients with type 2 diabetes using dapagliflozin compared to glibenclamide.

Posted by on Oct 31, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the change in central retinal thickness (CRT) by optical coherence tomography (OCT) in patients with type 2 diabetes (T2D) after 12 weeks of treatment with dapagliflozin (Farxiga) or glibenclamide (Diabeta). The authors concluded that CRT may improve with short-term use of dapagliflozin compared with...

Read More

Do insulin analogues differ in effectiveness and safety for the treatment of diabetes?

Do insulin analogues differ in effectiveness and safety for the treatment of diabetes?

Posted by on Oct 25, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the effectiveness and safety of different long-acting and short-acting insulins for the treatment of patients with diabetes. The data supported the use of long-acting insulins instead of neutral protamine Hagedorn (NPH) insulin (Humulin N; Novolin N), as basal insulin for patients with type 2 diabetes (T2D). Some...

Read More

Is closed-loop glucose control an effective treatment for patients with type 2 diabetes with serious kidney disease?

Is closed-loop glucose control an effective treatment for patients with type 2 diabetes with serious kidney disease?

Posted by on Sep 5, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study looked at the use of closed-loop glucose control treatment for patients with type 2 diabetes (T2D) requiring dialysis. It found that compared to standard insulin therapy, closed-loop glucose control led to improved glucose control in these patients.  Some background Closed-loop glucose control is a form of insulin...

Read More

Can a vegan diet improve diabetes?

Can a vegan diet improve diabetes?

Posted by on Aug 27, 2021 in Diabetes mellitus | 0 comments

In a nutshell This review looked at whether a vegan diet can improve type 2 diabetes (T2D). It found that a vegan diet can lower glucose (sugar) levels for people with T2D. Some background Vegan diets have become more popular, for both health and ethical reasons. A vegan diet includes plant-based foods and avoids meat, eggs, or dairy. But can a vegan...

Read More

Do SGLT2 inhibitors increase the risk of urogenital infections in patients with diabetes?

Do SGLT2 inhibitors increase the risk of urogenital infections in patients with diabetes?

Posted by on Aug 22, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study looked at the risk of urogenital infections in patients with diabetes taking sodium-glucose co-transporter 2 (SGLT2) inhibitors. It found that SGLT2 inhibitors increase the risk of urogenital infections in women over 50 years of age, especially in the first month of treatment. Some background SGLT 2 inhibitors such...

Read More

Is tirzepatide as effective as semaglutide for the treatment of type 2 diabetes?

Is tirzepatide as effective as semaglutide for the treatment of type 2 diabetes?

Posted by on Aug 15, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study looked at tirzepatide, a new treatment for type 2 diabetes, compared to semaglutide (Ozempic).  It found that, depending on the dose, tirzepatide was similarly or more effective at controlling blood glucose than semaglutide.  Some background Tirzepatide is a new type of medication designed to treat type 2...

Read More

Can SGLT2 inhibitors prevent liver disease for people with diabetes?

Can SGLT2 inhibitors prevent liver disease for people with diabetes?

Posted by on Aug 7, 2021 in Diabetes mellitus | 0 comments

In a nutshell This review looked at whether sodium-glucose cotransporter 2 (SGLT2) inhibitors can improve non-alcoholic fatty liver disease (NAFLD) for people with type 2 diabetes (T2D). It found that these medications can improve liver function in these patients. Some background NAFLD is a condition in which fat builds up in the liver. This makes the...

Read More

Can exercise improve nerve health of the heart in patients with diabetes?

Can exercise improve nerve health of the heart in patients with diabetes?

Posted by on Jul 11, 2021 in Diabetes mellitus | 0 comments

In a nutshell This review looked at whether exercise can improve heart rate variability (HRV) for patients with type 2 diabetes (T2D). It found that exercise improved HRV, which indicates better nerve health of the heart. Some background Over time, high blood glucose (sugar) from diabetes can cause nerve damage or neuropathy. People with diabetes...

Read More

Does lipoprotein A level affect kidney disease in patients with type 2 diabetes?

Does lipoprotein A level affect kidney disease in patients with type 2 diabetes?

Posted by on May 9, 2021 in Diabetes mellitus | 0 comments

In a nutshell This review looked at levels of lipoprotein A (LpA), in people with type 2 diabetes (T2D). It found that people with higher levels LpA in their blood were more likely to have kidney disease. Some background For people living with T2D, an important consideration is managing long-term health and preventing complications. T2D involves...

Read More

The effect of adding henagliflozin treatment to metformin in patients with type 2 diabetes.

The effect of adding henagliflozin treatment to metformin in patients with type 2 diabetes.

Posted by on May 9, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effectiveness of adding henagliflozin (SHR3824) to metformin (Glucophage) in patients with uncontrolled type 2 diabetes (T2D). The authors concluded that the addition of 5 mg or 10 mg of henagliflozin to metformin was well-tolerated and effective in these patients.  Some background...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor